Insulin resistance is considered to be an adverse metabolic and a key risk factor for developing cardiovascular diseases [13], and insulin receptor substrates (IRS) are key modulators of insulin signal transduction pathways in the heart. This evidence concerns the gene INSR and Insulin resistance.